Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Russia
Pharma
Regeneron expects approval delay of Libtayo plus chemo in NSCLC
A Libtayo-chemotherapy combo in lung cancer is unlikely to clinch approval until after its FDA action date next month, Regeneron's CEO said Wednesday.
Fraiser Kansteiner
Aug 3, 2022 12:35pm
EY looks at ways pharma can bolster its future supply chains
Jul 18, 2022 8:33am
Pfizer's Russian profit donation plan running smoothly, CEO says
Jun 22, 2022 2:14pm
BMS is pulling the plug on its Russian operations
Jun 2, 2022 10:09am
Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia
May 20, 2022 9:15am
With sales booming, Dr. Reddy's to launch new brands in Russia
May 19, 2022 10:46am
